| Literature DB >> 35291480 |
Eisuke Kogure1, Takeshi Ohnuma1, Yuta Sugita2,3, Tsuyoshi Hara4.
Abstract
[Purpose] The purpose of this study was to investigate the differences in respiratory function, physical function, and Activities of Daily Living (ADL) between respiratory and non-respiratory patients using community-based home rehabilitation. [Participations and Methods] Maximum Phonation Time (MPT), upper and lower limb muscle strength, and ADL were compared in two groups: a respiratory disease group including respiratory patients and those with respiratory comorbidities, and a non-respiratory disease group. Cutoff values were determined for items that showed significant differences between groups.Entities:
Keywords: Community-based rehabilitation; Maximum phonation time; Respiration disorders
Year: 2022 PMID: 35291480 PMCID: PMC8918101 DOI: 10.1589/jpts.34.213
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Details of the participant criteria.
Attributes of the participants
| All participants | Respiratorydisease group | Non-respiratory disease group | ||
| n=115 | n=19 | n=96 | ||
| Age (years)* | 76.5 ± 11.4 | 83.3 ± 6.5 | 75.2 ± 11.7 | |
| Gender (n)* | Males | 66 (57.4%) | 16 (84.2%) | 50 (52.1%) |
| Females | 49 (42.6%) | 3 (15.8%) | 46 (47.9%) | |
| Duration of home-visit rehabilitation (months) | 33.3 ± 32.9 | 28.0 ± 24.9 | 34.3 ± 34.2 | |
| Main disease (n) | Cerebrovascular disease | 34 (36.9%) | 4 (21.1%) | 30 (31.3%) |
| Musculoskeletal disease | 31 (33.6%) | 3 (15.8%) | 28 (29.2%) | |
| Neuromuscular disease | 21 (22.8%) | 1 (5.3%) | 20 (20.8%) | |
| Cardiovascular disease | 5 (5.4%) | 2 (10.5%) | 3 (3.1%) | |
| Respiratory disease | 6 (6.5%) | 6 (31.6%) | 0 (0%) | |
| Cancer | 4 (4.3%) | 2 (10.5%) | 2 (2.1%) | |
| Others | 14 (15.2%) | 1 (5.3%) | 13 (13.5%) | |
| Comorbidity ofrespiratory disease (n) | Bronchial asthma | 5 (4.3%) | 5 (26.3%) | |
| Interstitial pneumonia | 1 (0.9%) | 1 (5.3%) | ||
| Chronic obstructive pulmonary disease | 6 (5.2%) | 6 (31.6%) | ||
| Bronchitis | 2 (1.7%) | 2 (10.5%) | ||
| Chronic respiratory insufficiency | 2 (1.7%) | 2 (10.5%) | ||
| Lung cancer | 2 (1.7%) | 2 (10.5%) | ||
| Chronic cough | 1 (0.9%) | 1 (5.3%) | ||
| MPT (sec)* | 12.8 ± 6.9 | 8.9 ± 5.7 | 13.5 ± 6.8 | |
| Hand grip (kg) | 20.5 ± 8.4 | 18.4 ± 7.5 | 20.9 ± 8.6 | |
| CS-30 (times) | 4.4 ± 5.5 | 3.9 ± 5.9 | 4.5 ± 5.4 | |
| Motor FIM (points) | 72.4 ± 14.6 | 69.8 ± 16.5 | 72.9 ± 14.2 | |
| Cogenitive FIM (points) | 32.5 ± 4.4 | 31.2 ± 6.0 | 32.7 ± 4.1 | |
| Total FIM (points) | 104.8 ± 17.0 | 101.0 ± 21.4 | 105.6 ± 16.1 | |
| LSA (points) | 30.7 ± 16.0 | 26.3 ± 22.5 | 31.5 ± 14.4 | |
Values are presented as mean ± standard deviation or number (%).
*p<0.05, statistically significant.
MPT: Maximum Phonation Time; CS-30: 30-seconds Chair-Stand test; FIM: Functional Independence Measure; LSA: Life Space Assessment.
Fig. 2.Receiver operating characteristics curve of maximum phonation time.
The MPT cutoff value for the presence of respiratory disease was calculated using the Youden index.
Details of each group at maximum phonation time cutoff
| Respiratory disease group | Non-respiratory disease group | Total (n) | |
| n=19 | n=96 | ||
| <10.1 sec (n) | 15 | 33 | 48 |
| >10.1 sec (n) | 4 | 63 | 67 |
| Total (n) | 19 | 96 | 115 |